BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1257 related articles for article (PubMed ID: 33556379)

  • 21. Susceptibility and Attenuated Transmissibility of SARS-CoV-2 in Domestic Cats.
    Bao L; Song Z; Xue J; Gao H; Liu J; Wang J; Guo Q; Zhao B; Qu Y; Qi F; Gong S; Liu M; Lv Q; Li D; Han Y; Zhao W; Deng S; Liu Y; Xiang Z; Yang B; Deng W; Yu H; Cong Z; Wei Q; Xu J; Gao GF; Qin C
    J Infect Dis; 2021 Apr; 223(8):1313-1321. PubMed ID: 33605423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Self-Collected Oral Fluid Saliva Is Insensitive Compared With Nasal-Oropharyngeal Swabs in the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 in Outpatients.
    Manabe YC; Reuland C; Yu T; Azamfirei R; Hardick JP; Church T; Brown DM; Sewell TT; Antar A; Blair PW; Heaney CD; Pekosz A; Thomas DL;
    Open Forum Infect Dis; 2021 Feb; 8(2):ofaa648. PubMed ID: 33604399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative assessment of SARS-CoV-2 RNAemia and outcome in patients with coronavirus disease 2019.
    Tang K; Wu L; Luo Y; Gong B
    J Med Virol; 2021 May; 93(5):3165-3175. PubMed ID: 33590923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Causal network models of SARS-CoV-2 expression and aging to identify candidates for drug repurposing.
    Belyaeva A; Cammarata L; Radhakrishnan A; Squires C; Yang KD; Shivashankar GV; Uhler C
    Nat Commun; 2021 Feb; 12(1):1024. PubMed ID: 33589624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers.
    Adrielle Dos Santos L; Filho PGG; Silva AMF; Santos JVG; Santos DS; Aquino MM; de Jesus RM; Almeida MLD; da Silva JS; Altmann DM; Boyton RJ; Alves Dos Santos C; Santos CNO; Alves JC; Santos IL; Magalhães LS; Belitardo EMMA; Rocha DJPG; Almeida JPP; Pacheco LGC; Aguiar ERGR; Campos GS; Sardi SI; Carvalho RH; de Jesus AR; Rezende KF; de Almeida RP
    J Infect; 2021 Mar; 82(3):399-406. PubMed ID: 33589297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Public health actions to control new SARS-CoV-2 variants.
    Grubaugh ND; Hodcroft EB; Fauver JR; Phelan AL; Cevik M
    Cell; 2021 Mar; 184(5):1127-1132. PubMed ID: 33581746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoreactive peptide maps of SARS-CoV-2.
    Mishra N; Huang X; Joshi S; Guo C; Ng J; Thakkar R; Wu Y; Dong X; Li Q; Pinapati RS; Sullivan E; Caciula A; Tokarz R; Briese T; Lu J; Lipkin WI
    Commun Biol; 2021 Feb; 4(1):225. PubMed ID: 33580175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers: a cross-sectional study.
    Ebinger JE; Botwin GJ; Albert CM; Alotaibi M; Arditi M; Berg AH; Binek A; Botting P; Fert-Bober J; Figueiredo JC; Grein JD; Hasan W; Henglin M; Hussain SK; Jain M; Joung S; Karin M; Kim EH; Li D; Liu Y; Luong E; McGovern DPB; Merchant A; Merin N; Miles PB; Minissian M; Nguyen TT; Raedschelders K; Rashid MA; Riera CE; Riggs RV; Sharma S; Sternbach S; Sun N; Tourtellotte WG; Van Eyk JE; Sobhani K; Braun JG; Cheng S
    BMJ Open; 2021 Feb; 11(2):e043584. PubMed ID: 33579769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome.
    Rosas-Salazar C; Kimura KS; Shilts MH; Strickland BA; Freeman MH; Wessinger BC; Gupta V; Brown HM; Rajagopala SV; Turner JH; Das SR
    J Allergy Clin Immunol; 2021 Apr; 147(4):1226-1233.e2. PubMed ID: 33577896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic mutations and changes in protein secondary structure and solvent accessibility of SARS-CoV-2 (COVID-19 virus).
    Nguyen TT; Pathirana PN; Nguyen T; Nguyen QVH; Bhatti A; Nguyen DC; Nguyen DT; Nguyen ND; Creighton D; Abdelrazek M
    Sci Rep; 2021 Feb; 11(1):3487. PubMed ID: 33568759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphometry of SARS-CoV and SARS-CoV-2 particles in ultrathin plastic sections of infected Vero cell cultures.
    Laue M; Kauter A; Hoffmann T; Möller L; Michel J; Nitsche A
    Sci Rep; 2021 Feb; 11(1):3515. PubMed ID: 33568700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reply to Ma and Wang: Reliability of various in vitro activity assays on SARS-CoV-2 main protease inhibitors.
    Li Z; Lin Y; Huang YY; Liu R; Zhan CG; Wang X; Luo HB
    Proc Natl Acad Sci U S A; 2021 Feb; 118(8):. PubMed ID: 33568500
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative Performance Testing of Respirator versus Surgical Mask Using a Water Droplet Spray Model.
    Scheepers PTJ; Wertheim HFL; van Dael M; Anzion R; Holterman HJ; Teerenstra S; de Groot M; Voss A; Hopman J
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33567665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Morphology and morphogenesis of SARS-CoV-2 in Vero-E6 cells.
    Barreto-Vieira DF; da Silva MAN; Garcia CC; Miranda MD; Matos ADR; Caetano BC; Resende PC; Motta FC; Siqueira MM; Girard-Dias W; Archanjo BS; Barth OM
    Mem Inst Oswaldo Cruz; 2021; 116():e200443. PubMed ID: 33566951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The basis of a more contagious 501Y.V1 variant of SARS-COV-2.
    Liu H; Zhang Q; Wei P; Chen Z; Aviszus K; Yang J; Downing W; Peterson S; Jiang C; Liang B; Reynoso L; Downey GP; Frankel SK; Kappler J; Marrack P; Zhang G
    bioRxiv; 2021 Feb; ():. PubMed ID: 33564771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutralization of viruses with European, South African, and United States SARS-CoV-2 variant spike proteins by convalescent sera and BNT162b2 mRNA vaccine-elicited antibodies.
    Tada T; Dcosta BM; Samanovic-Golden M; Herati RS; Cornelius A; Mulligan MJ; Landau NR
    bioRxiv; 2021 Feb; ():. PubMed ID: 33564768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The potential use of lactate blockers for the prevention of COVID-19 worst outcome, insights from exercise immunology.
    AbdelMassih AF; Menshawey R; Hozaien R; Kamel A; Mishriky F; Husseiny RJ; Hanoura AM; Yacoub E; AlShehry N; Menshawey E; El-Husseiny N; Yasser R; Arsanyous M; Nathan L; Seyam M; Massoud D; Ali N; Kassim A; AmanAllah M; Elsayed R; Sheashaa H; Husseiny Y; Hassan NH; Badr K; Elkhateb A; Fouad V; Elfishawy M; Medhat O; Mustafa M; Khalil N; Elsayed R; Nada Y; Elshawarbi P; Abdelmoneim N; Gamal N; Messiha M; Ghazy M; Abdelfatah E; Nasry F; Gayed R; Eesa M; Luis M; Eskandar E; Yacoub S; Saud A; Rajab M; Abdelaziz M; Elgamal N; Jaber H; Tayssir S; Michael M; Sabry A; Shehata J; Abdelaziz R; Rateb S; El-Maghraby A; Mahjoub Y; Amr A; Mabrouk A; Kelada P; Ragab S; Eltaher B; Hassan Galal R; Aly OM; Aly T; AbdelHaleem R; ElShaarawy A; Mohamed O
    Med Hypotheses; 2021 Mar; 148():110520. PubMed ID: 33561624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Respiratory co-infections with COVID-19 in the Veterans Health Administration, 2020.
    Schirmer P; Lucero-Obusan C; Sharma A; Sohoni P; Oda G; Holodniy M
    Diagn Microbiol Infect Dis; 2021 May; 100(1):115312. PubMed ID: 33561606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The
    Hu Y; Meng X; Zhang F; Xiang Y; Wang J
    Emerg Microbes Infect; 2021 Dec; 10(1):317-330. PubMed ID: 33560940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Olfactory and taste dysfunctions in COVID-19.
    Rouadi PW; Idriss SA; Bousquet J
    Curr Opin Allergy Clin Immunol; 2021 Jun; 21(3):229-244. PubMed ID: 33560742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 63.